Publications by authors named "Lisa A Moreau"

24Publications

p31 promotes homologous recombination by inactivating REV7 through the TRIP13 ATPase.

Proc Natl Acad Sci U S A 2020 10 13;117(43):26795-26803. Epub 2020 Oct 13.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215;

View Article and Find Full Text PDF
October 2020

Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection.

Cell Rep 2020 02;30(7):2402-2415.e5

Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address:

View Article and Find Full Text PDF
February 2020

Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.

Cancer Discov 2015 Feb 3;5(2):135-42. Epub 2014 Dec 3.

Department of Cancer Biology, Abramson Family Cancer Research Institute, Basser Research Center for BRCA, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Department of Pathology, Abramson Family Cancer Research Institute, Basser Research Center for BRCA, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article and Find Full Text PDF
February 2015

Overcoming reprogramming resistance of Fanconi anemia cells.

Blood 2012 Jun 27;119(23):5449-57. Epub 2012 Feb 27.

Division of Pediatric Hematology/Oncology, Children's Hospital Boston, and Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article and Find Full Text PDF
June 2012

Inhibition of the Nedd8 system sensitizes cells to DNA interstrand cross-linking agents.

Mol Cancer Res 2012 Mar 4;10(3):369-77. Epub 2012 Jan 4.

Department of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, Florida, USA.

View Article and Find Full Text PDF
March 2012

Human MutS and FANCM complexes function as redundant DNA damage sensors in the Fanconi Anemia pathway.

DNA Repair (Amst) 2011 Dec 4;10(12):1203-12. Epub 2011 Oct 4.

Department of Radiation Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA 02215, United States.

View Article and Find Full Text PDF
December 2011

Histone H3 methylation links DNA damage detection to activation of the tumour suppressor Tip60.

Nat Cell Biol 2009 Nov 27;11(11):1376-82. Epub 2009 Sep 27.

Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney St, Boston, MA 02115, USA.

View Article and Find Full Text PDF
November 2009

Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability.

Mol Cell Biol 2008 Oct 18;28(20):6223-33. Epub 2008 Aug 18.

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology/Oncology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article and Find Full Text PDF
October 2008

RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites.

Science 2007 May;316(5828):1198-202

Dana-Farber Cancer Institute and Department of Genetics and Department of Medicine, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.

View Article and Find Full Text PDF
May 2007

Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.

J Clin Invest 2007 May 12;117(5):1440-9. Epub 2007 Apr 12.

Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.

View Article and Find Full Text PDF
May 2007

Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.

PLoS One 2007 Feb 28;2(2):e255. Epub 2007 Feb 28.

Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.

View Article and Find Full Text PDF
February 2007